ASKA PHARMACEUTICAL CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1929-06-28
- Employees
- 501
- Market Cap
- -
- Website
- http://www.aska-pharma.co.jp
Clinical Trials
31
Active:2
Completed:16
Trial Phases
3 Phases
Phase 2:6
Phase 3:9
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (18 trials with phase data)• Click on a phase to view related trials
Phase 3
9 (50.0%)Phase 2
6 (33.3%)phase_2_3
2 (11.1%)Not Applicable
1 (5.6%)Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis
- First Posted Date
- 2019-04-30
- Last Posted Date
- 2020-12-11
- Lead Sponsor
- ASKA Pharmaceutical Co., Ltd.
- Target Recruit Count
- 335
- Registration Number
- NCT03931915
- Locations
- 🇯🇵
Chubu Rosai Hospital, Aichi, Japan
🇯🇵Meitetsu Hospital, Aichi, Japan
🇯🇵Aiiku Ladies Clinic, Chiba, Japan
News
No news found